Pure Global

Non-inferiority of Portable Versus Desktop Spirometry - Trial NCT03894475

Access comprehensive clinical trial information for NCT03894475 through Pure Global AI's free database. This phase not specified trial is sponsored by National Institute for Tuberculosis and Lung Diseases, Poland and is currently Completed. The study focuses on Asthma,COPD. Target enrollment is 62 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT03894475
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT03894475
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Non-inferiority of Portable Versus Desktop Spirometry

Study Focus

Asthma,COPD

AioCare

Interventional

device

Sponsor & Location

National Institute for Tuberculosis and Lung Diseases, Poland

Warsaw, Poland

Timeline & Enrollment

N/A

Dec 18, 2017

Jun 21, 2018

62 participants

Primary Outcome

Non-inferiority of PEF between AioCare and CPFS/D USB Spirometer,Non-inferiority of FEV1 between AioCare and CPFS/D USB Spirometer,Non-inferiority of FVC between AioCare and CPFS/D USB Spirometer

Summary

The investigators compared the ventilation parameters for volume and flow obtained from
 standard spirometry procedures from patients presently monitored and treated for asthma or
 chronic obstructive pulmonary disease (COPD) using AioCare (HealthUp Sp. z o.o., Serial
 Number: MS082017005412, software version: MySpiroo app 1.1.14) as the tested device and
 Spirometer USB CPFS/D (MGC Diagnostics) as the reference, which required calibration prior to
 each session. Spirometry measurements were performed on sixty-two patients (forty-four
 females (58ยฑ17 years old) and eighteen males (52ยฑ19 years old)) at the Institute of
 Tuberculosis and Lung Disease in Warsaw, Poland. Participants were asked to perform correct
 spirometry examinations (which means at least three technically correct exhales and meeting
 repeatability criteria for FEV1 and FVC) on both measuring devices with a five-minute break
 between devices to prevent respiratory muscle fatigue. The highest value from all acceptable
 spirometry results was then used for analysis. All spirometry examinations followed ERS/ATS
 standards.

ICD-10 Classifications

Asthma
Asthma, unspecified
Nonallergic asthma
Mixed asthma
Other chronic obstructive pulmonary disease

Data Source

ClinicalTrials.gov

NCT03894475

Device Trial